Reaction

Prostate Cancer Metastatic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,308 reports · 49 co-occurring drugs

As of the last recalculation, Prostate Cancer Metastatic appears in 3,308 FAERS reports alongside 49 co-occurring drug terms. The strongest observed disproportionality signal is ABIRATERONE (PRR 142.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Abiraterone	283	142.9	146.0
Bicalutamide	289	130.7	133.2
Abiraterone Acetate	656	124.9	126.9
Leuprolide Acetate	684	69.7	70.3
Goserelin	114	55.3	55.8
Apalutamide	80	43.9	44.1
Lutetium Lu 177 Vipivotide Tetraxetan	79	38.6	38.8
Enzalutamide	312	36.8	37.0
Docetaxel Anhydrous	246	24.7	24.8
Docetaxel	246	24.7	24.8
Dutasteride	17	13.2	13.2
Standardized Senna Concentrate	24	12.1	12.1
Relugolix	43	11.6	11.6
Ketoconazole Foam	24	10.3	10.3
Ketoconazole Cream, 2%	24	10.2	10.3
Zoledronic Acid	61	9.7	9.7
Ketoconazole	25	9.1	9.2
Olaparib	29	8.8	8.8
Denosumab	261	8.7	8.7
Rucaparib	11	7.9	7.9
Bisacodyl	14	6.3	6.3
Granisetron	10	6.0	6.0
Bisacodyl Suppositories	12	5.9	5.9
Biscodyl	12	5.8	5.8
Thalidomide	32	5.5	5.5
Granisetron Hydrochloride	9	5.4	5.4
Prednisolone	148	5.4	5.4
Prednisolone Oral	148	5.4	5.4
Prednisolone Oral Solution	148	5.4	5.4
Sotalol Hydrochloride	14	5.3	5.3
Naproxen Sodium Tablet, Coated	11	5.1	5.1
Naproxen Sodium, Coated Tablets	11	5.1	5.1
Naproxen Sodium 220Mg	11	5.1	5.1
Fentanyl	73	4.7	4.7
Metoclopramide	41	4.7	4.7
Lactulose	28	4.6	4.6
Sirolimus	9	4.2	4.2
Finasteride	39	4.1	4.1
Doxazosin	18	4.1	4.1
Timolol	7	3.7	3.7
Tafamidis	6	3.2	3.2
Carboplatin	61	3.1	3.1
Dexamethasone 1.5 Mg	136	3.0	3.0
Miconazole Nitrate	4	2.9	2.9
Dronedarone	4	2.5	2.5
Inclisiran	3	2.4	2.4
Ranibizumab	8	1.9	1.9
Sacubitril And Valsartan	26	1.4	1.4
Pimavanserin Tartrate	7	0.8	0.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.